Aida Spahic
About Aida Spahic
Aida Spahic is the Director of Commercial Operations at Nektar Therapeutics, with extensive experience in the pharmaceuticals industry, including roles at Portola Pharmaceuticals and Pharmacyclics. She holds an MBA in Marketing and a degree in Accounting and Finance, and possesses strong analytical skills and expertise in strategic planning.
Work at Nektar Therapeutics
Currently, Aida Spahic serves as the Director of Commercial Operations at Nektar Therapeutics. She has held this position since 2020, contributing to the company's strategic initiatives in the pharmaceuticals sector. Her role involves overseeing commercial operations, leveraging her extensive background in marketing and analytics to drive business performance.
Previous Experience at Portola Pharmaceuticals
Aida Spahic worked at Portola Pharmaceuticals as the Associate Director of Global Marketing for a period of 10 months from 2019 to 2020. During her tenure in South San Francisco, California, she focused on strategic marketing initiatives that aligned with the company's objectives in the pharmaceuticals industry.
Career at Pharmacyclics, an AbbVie Company
From 2017 to 2019, Aida Spahic held the position of Senior Manager for Imbruvica Marketing Operations at Pharmacyclics, an AbbVie Company. Her responsibilities included managing marketing strategies for Imbruvica, a key product in the company's portfolio, during her two-year tenure in Sunnyvale, California.
Education and Expertise
Aida Spahic earned her Bachelor’s degree in Accounting and Finance from Indiana University South Bend, where she studied from 2001 to 2005. She later obtained a Master of Business Administration (MBA) with a focus on Marketing from Lake Forest Graduate School of Management, completing her studies from 2013 to 2015. Her educational background supports her expertise in strategic planning and organizational behavior within the pharmaceuticals industry.
Background in Analytics and Leadership
Aida Spahic has a strong foundation in analytics, which plays a crucial role in her current position in commercial operations. Her background in organizational behavior enhances her leadership capabilities, enabling her to effectively manage teams and drive strategic initiatives in the pharmaceuticals sector.